SweetValueLab
Write for us

Albemarle Corporation — Wall Street Analyst Estimates & Price Targets

ALB
NYSEBasic MaterialsChemicals - SpecialtyCIK 0000915913albemarle.comAbout ALB
Last close · Oct 16, 202695.48−2.70 (−2.75%)
Market cap$11.3B

9 firms' latest targets, last 90 days: median $150.00 ($109.00–$225.00), 57% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$100$150$200$250NovJan 2026MarMayJulSep2025-10-20 · Truist: $87.02025-11-10 · Scotiabank: $85.02025-11-19 · BMO Capital: $1362025-12-02 · Baird: $1132025-12-03 · Deutsche Bank: $1252025-12-05 · UBS: $1852025-12-16 · Morgan Stanley: $1472025-12-17 · Truist: $1252025-12-18 · RBC Capital: $1592025-12-18 · Mizuho Securities: $1322026-01-05 · Jefferies: $1672026-01-07 · Baird: $2102026-01-12 · Deutsche Bank: $1852026-01-12 · Mizuho Securities: $1562026-01-12 · UBS: $2052026-01-12 · Scotiabank: $2002026-01-19 · HSBC: $2002026-01-21 · RBC Capital: $2002026-01-21 · Oppenheimer: $2072026-01-21 · Truist: $2052026-01-26 · Wells Fargo: $1742026-02-12 · Mizuho Securities: $1852026-02-13 · Morgan Stanley: $1702026-02-16 · Wells Fargo: $1652026-02-17 · RBC Capital: $2162026-02-18 · Evercore ISI: $1802026-02-23 · Berenberg Bank: $1532026-03-06 · Truist: $2102026-04-09 · UBS: $2302026-04-14 · Morgan Stanley: $1892026-04-24 · RBC Capital: $2452026-05-08 · UBS: $2642026-05-08 · Truist: $2602026-05-11 · RBC Capital: $2532026-05-11 · Argus Research: $2302026-05-12 · Deutsche Bank: $2502026-05-14 · Scotiabank: $2152026-05-26 · RBC Capital: $2572026-05-26 · Vertical Research: $2242026-07-17 · RBC Capital: $1662026-08-07 · Truist: $2252026-08-07 · UBS: $1752026-08-10 · Scotiabank: $1902026-08-10 · Morgan Stanley: $1612026-10-01 · Mizuho Securities: $1302026-10-05 · UBS: $1502026-10-06 · BMO Capital: $1752026-10-07 · Argus Research: $1352026-10-12 · Barclays: $1092026-10-15 · RBC Capital: $129
$100$150$200$250NovFebMayAug

Each firm's latest target

last 90 days · 9 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-15RBC Capital$129.00$166.00▼ 22%+32%+35%
2026-10-12Barclays$109.00——+11%+14%
2026-10-07Argus Research$135.00$230.00▼ 41%+30%+41%
2026-10-06BMO Capital$175.00$136.00▲ 29%+64%+83%
2026-10-05UBS$150.00$175.00▼ 14%+43%+57%
2026-10-01Mizuho Securities$130.00$185.00▼ 30%+23%+36%
2026-08-10Scotiabank$190.00$215.00▼ 12%+45%+99%
2026-08-10Morgan Stanley$161.00$189.00▼ 15%+23%+69%
2026-08-07Truist$225.00$260.00▼ 13%+75%+136%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$9.6B+31%$13.36-42%est. $9.4B+2%est. $21.3916
2024reported$5.4B-44%-$11.20-184%est. $5.5B-2%est. -$1.7615
2025reported$5.1B-4%-$5.76—est. $5.1B+2%est. -$0.7816
2026$6.1B+19%$11.29—$6.0B–$6.2B$9.62–$13.0914
2027$6.2B+2%$10.22-9%$6.0B–$6.5B$7.10–$13.3814
2028$6.3B+2%$10.82+6%$4.9B–$7.9B$6.01–$15.3414
2029$6.3B+0%$10.60-2%$5.7B–$7.3B$9.14–$12.628
2030$7.4B+17%$13.90+31%$6.6B–$8.5B$11.99–$16.5512
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.